Literature DB >> 23938594

Nephrotic syndrome: Rituximab in childhood steroid-dependent nephrotic syndrome.

Olivia Boyer1, Patrick Niaudet.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23938594     DOI： 10.1038/nrneph.2013.153

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  10 in total

1.  Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis.

Authors:  Alessia Fornoni; Junichiro Sageshima; Changli Wei; Sandra Merscher-Gomez; Robier Aguillon-Prada; Alexandra N Jauregui; Jing Li; Adela Mattiazzi; Gaetano Ciancio; Linda Chen; Gaston Zilleruelo; Carolyn Abitbol; Jayanthi Chandar; Wacheree Seeherunvong; Camillo Ricordi; Masami Ikehata; Maria Pia Rastaldi; Jochen Reiser; George W Burke
Journal:  Sci Transl Med       Date:  2011-06-01       Impact factor: 17.956

2.  Fatal pulmonary fibrosis after rituximab administration.

Authors:  Marie-Camille Chaumais; Arnaud Garnier; François Chalard; Michel Peuchmaur; Stephane Dauger; Evelyne Jacqz-Agrain; Georges Deschênes
Journal:  Pediatr Nephrol       Date:  2009-04-25       Impact factor: 3.714

3.  Increased expression of the FoxP3 functional marker of regulatory T cells following B cell depletion with rituximab in patients with lupus nephritis.

Authors:  P P Sfikakis; V L Souliotis; K G Fragiadaki; H M Moutsopoulos; J N Boletis; A N Theofilopoulos
Journal:  Clin Immunol       Date:  2007-01-31       Impact factor: 3.969

Review 4.  Treatment of steroid-sensitive nephrotic syndrome: new guidelines from KDIGO.

Authors:  Rebecca M Lombel; Debbie S Gipson; Elisabeth M Hodson
Journal:  Pediatr Nephrol       Date:  2012-10-03       Impact factor: 3.714

5.  Cyclosporine versus mycophenolate mofetil for maintenance of remission of steroid-dependent nephrotic syndrome after a single infusion of rituximab.

Authors:  Shuichiro Fujinaga; Tomonosuke Someya; Tsuneki Watanabe; Akira Ito; Yoshiyuki Ohtomo; Toshiaki Shimizu; Kazunari Kaneko
Journal:  Eur J Pediatr       Date:  2012-12-28       Impact factor: 3.183

6.  Fulminant viral myocarditis after rituximab therapy in pediatric nephrotic syndrome.

Authors:  Anne-Laure Sellier-Leclerc; Emre Belli; Valérie Guérin; Peter Dorfmüller; Georges Deschênes
Journal:  Pediatr Nephrol       Date:  2013-05-23       Impact factor: 3.714

Review 7.  Rituximab therapy in nephrotic syndrome: implications for patients' management.

Authors:  Aditi Sinha; Arvind Bagga
Journal:  Nat Rev Nephrol       Date:  2013-01-22       Impact factor: 28.314

8.  Does rituximab induce hypogammaglobulinemia in patients with pediatric idiopathic nephrotic syndrome?

Authors:  Laëtitia Delbe-Bertin; Bilal Aoun; Elena Tudorache; Hélène Lapillone; Tim Ulinski
Journal:  Pediatr Nephrol       Date:  2012-12-05       Impact factor: 3.714

9.  Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome.

Authors:  Pietro Ravani; Alessandro Ponticelli; Chiara Siciliano; Alessia Fornoni; Alberto Magnasco; Felice Sica; Monica Bodria; Gianluca Caridi; Changli Wei; Mirco Belingheri; Luciana Ghio; Sandra Merscher-Gomez; Alberto Edefonti; Andrea Pasini; Giovanni Montini; Corrado Murtas; Xiangyu Wang; Daniel Muruve; Augusto Vaglio; Davide Martorana; Antonello Pani; Francesco Scolari; Jochen Reiser; Gian M Ghiggeri
Journal:  Kidney Int       Date:  2013-06-05       Impact factor: 10.612

10.  Maintenance therapy with mycophenolate mofetil after rituximab in pediatric patients with steroid-dependent nephrotic syndrome.

Authors:  Shuichi Ito; Koichi Kamei; Masao Ogura; Mai Sato; Takuya Fujimaru; Tomoaki Ishikawa; Tomohiro Udagawa; Kazumoto Iijima
Journal:  Pediatr Nephrol       Date:  2011-05-10       Impact factor: 3.651
  10 in total
  3 in total

1.  Positive role of rituximab in switching from cyclosporine to mycophenolate mofetil for children with high-dose steroid-dependent nephrotic syndrome.

Authors:  Shuichiro Fujinaga; Koji Sakuraya; Akifumi Yamada; Yasuko Urushihara; Yoshiyuki Ohtomo; Toshiaki Shimizu
Journal:  Pediatr Nephrol       Date:  2015-01-10       Impact factor: 3.714

Review 2.  Minimal Change Disease.

Authors:  Marina Vivarelli; Laura Massella; Barbara Ruggiero; Francesco Emma
Journal:  Clin J Am Soc Nephrol       Date:  2016-12-09       Impact factor: 8.237

3.  Genetic testing in the diagnosis of chronic kidney disease: recommendations for clinical practice.

Authors:  Nine Knoers; Corinne Antignac; Carsten Bergmann; Karin Dahan; Sabrina Giglio; Laurence Heidet; Beata S Lipska-Ziętkiewicz; Marina Noris; Giuseppe Remuzzi; Rosa Vargas-Poussou; Franz Schaefer
Journal:  Nephrol Dial Transplant       Date:  2022-01-25       Impact factor: 5.992
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.